Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
Under the agreement, Fresh Tracks provided consulting services as an independent contractor to Botanix in support of and through filing and approval of the U.S. new drug application for BBI-4000 (sofpironium bromide gel).
Lead Product(s): Sofpironium Bromide
Therapeutic Area: Dermatology Product Name: BBI-4000
Highest Development Status: Phase IIIProduct Type: Small molecule
Recipient: Fresh Tracks Therapeutics
Deal Size: $8.2 million Upfront Cash: $8.2 million
Deal Type: Agreement July 21, 2023